[go: up one dir, main page]

Revision history of "Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma" (Q35117549)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 August 2023

27 March 2023

19 September 2022

27 May 2022

30 January 2022

16 May 2021

10 January 2021

29 July 2020

9 June 2020

9 November 2019

3 October 2019

  • curprev 08:5108:51, 3 October 2019 ԱշբոտՏՆՂ talk contribs 97,765 bytes +206 Changed label, description and/or aliases in 2 languages: hy:description:2014 թվականի մարտին հրատարակված գիտական հոդված, hyw:description:2014 թուականի Մարտին հրատարակուած գիտական յօդուած undo (restore)

24 April 2019

28 March 2019

19 February 2019

6 December 2018

4 November 2018

27 September 2018

9 July 2018

13 October 2017

  • curprev 14:3114:31, 13 October 2017 Emijrpbot talk contribs 35,143 bytes +4,693 Updated Item: BOT - Adding descriptions (57 languages): ar, ast, bg, bn, ca, cs, da, de, el, eo, es, et, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nl, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cy... undo (restore)

6 August 2017